只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-12 2026-06-12 | INR INFINITY NATURAL RESOURCES, INC. | GRAY STEVEN D Director | 买入（P） | 25,000 | US$12.81 | US$320,250.00 | 40,000 | SEC |
| 2026-06-11 2026-06-15 | INR INFINITY NATURAL RESOURCES, INC. | Quinn William J Director,TenPercentOwner | 买入（P） | 11,497 | US$13.20 | US$151,760.40 | 66,000 | SEC |
| 2026-06-11 2026-06-11 | INR INFINITY NATURAL RESOURCES, INC. | Poole David P Director | 买入（P） | 4,000 | US$13.50 | US$54,000.00 | 27,646 | SEC |
| 2026-06-10 2026-06-11 | INR INFINITY NATURAL RESOURCES, INC. | Poole David P Director | 买入（P） | 7,500 | US$14.00 | US$105,000.00 | 23,646 | SEC |
| 2026-06-05 2026-06-09 | TRUP TRUPANION, INC. | WEINRAUCH STEVE Officer · EVP, North Am & Vet Strategy | 卖出（S） | 6,674 | US$22.00 | US$146,828.00 | 78,062 | SEC |
| 2026-06-05 2026-06-08 | INR INFINITY NATURAL RESOURCES, INC. | Quinn William J Director,TenPercentOwner | 买入（P） | 44,000 | US$13.19 | US$580,360.00 | 54,503 | SEC |
| 2026-06-03 2026-06-05 | INR INFINITY NATURAL RESOURCES, INC. | Quinn William J Director,TenPercentOwner | 买入（P） | 10,503 | US$13.20 | US$138,639.60 | 10,503 | SEC |
| 2026-06-03 2026-06-03 | INR INFINITY NATURAL RESOURCES, INC. | Gieselman Scott Director | 买入（P） | 670 | US$13.44 | US$9,004.80 | 85,000 | SEC |
| 2026-06-02 2026-06-03 | INR INFINITY NATURAL RESOURCES, INC. | Gieselman Scott Director | 买入（P） | 13,430 | US$13.35 | US$179,290.50 | 84,330 | SEC |
| 2026-05-26 2026-05-27 | INR INFINITY NATURAL RESOURCES, INC. | Gieselman Scott Director | 买入（P） | 20,000 | US$14.10 | US$282,000.00 | 70,900 | SEC |
| 2026-05-22 2026-05-27 | INR INFINITY NATURAL RESOURCES, INC. | Gieselman Scott Director | 买入（P） | 900 | US$14.34 | US$12,906.00 | 50,900 | SEC |
| 2026-05-06 2026-05-06 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 311 | US$43.95 | US$13,668.45 | 113,238 | SEC |
| 2026-05-05 2026-05-06 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 2,174 | US$46.65 | US$101,417.10 | 113,549 | SEC |
| 2026-05-04 2026-05-06 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 20,000 | US$45.00 | US$900,000.00 | 111,473 | SEC |
| 2026-04-15 2026-04-15 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 1,018 | US$42.61 | US$43,376.98 | 111,473 | SEC |
| 2026-04-14 2026-04-15 | TVTX Travere Therapeutics, Inc. | Inrig Jula Officer · CHIEF MEDICAL OFFICER | 卖出（S） | 7,215 | US$41.93 | US$302,524.95 | 112,491 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| INR | 103,124.0986 | 776 | 126,682.6347 | 81.40% | Q, N |
| INRO | 218.1955 | 0 | 285.7371 | 76.36% | Q |
| AXINR | 3,398 | 0 | 72,562 | 4.68% | Q |